Top

Published in:

01-05-2009 | Original Article

Evolutive study of children with diffuse mesangial sclerosis

Authors: Ana Pilar Nso Roca, Antonia Peña Carrión, Marta Benito Gutiérrez, Carmen García Meseguer, Araceli García Pose, Mercedes Navarro

Published in: Pediatric Nephrology | Issue 5/2009

Abstract

Diffuse mesangial sclerosis (DMS) is a renal disease that usually presents as a nephrotic syndrome. It is characterized by early onset and rapid progression to end-stage renal disease, and can occur as an isolated finding or as part of the Denys-Drash syndrome. The aim of this study was to characterize clinical features and outcomes of DMS in a cohort of children. We retrospectively analyzed all cases of DMS diagnosed in our hospital between 1973 and 2008 and evaluated the progression of the disease in relation to different variables. We studied 14 patients, four with incomplete Denys-Drash syndrome and one with Frasier syndrome. All patients developed renal failure. Eight patients received a renal transplant with no relapse of the disease. Bilateral nephrectomy was performed in nine patients with end-stage renal disease. Seven patients died, with sepsis being the main cause of death. Diffuse mesangial sclerosis must be suspected in a child that presents with early onset proteinuria and/or rapidly progressive renal failure. Karyotype and WT1 gene analysis should be performed because of the predisposition of patients to develop different types of tumors. This nephropathy has a poor prognosis, but the survival rate has improved in the last decade.

Ito S, Takata A, Hataya H, Ikeda M, Kikuchi H, Hata J, Honda M (2001) Isolated diffuse mesangial sclerosis and Wilms tumor suppressor gene. J Pediatr 138:425–427CrossRef

Habib R, Bois E (1973) Heterogeneity of early onset nephrotic syndromes in infants (nephrotic syndrome "in infants"). Anatomical, clinical and genetic study of 37 cases. Helv Paediatr Acta 29:91–107

Heathcott RW, Morison IM, Gubler MC, Corbett R, Reeve AE (2002) A review of the phenotypic variation due to the Denys-Drash syndrome-associated germline WT1 mutation R362X. Hum Mutat 19:462CrossRef

Garcia-Torres R, Braun G, Ramon G (1992) Drash’s syndrome and its variants. A report of 3 cases. Bol Med Hosp Infant Mex 49:372–379PubMed

Gallo GE, Chemes HE (1987) The association of Wilms’ tumor, male pseudohermaphroditism and diffuse glomerular disease (Drash syndrome): report of eight cases with clinical and morphologic findings and review of the literature. Pediatr Pathol 7:175–189PubMed

Swiatecka-Urban A, Mokrzycki MH, Kaskel F, Da Silva F, Denamur E (2001) Novel WT1 mutation (C388Y) in a female child with Denys-Drash syndrome. Pediatr Nephrol 16:627–630CrossRef

Melocoton TL, Salusky IB, Hall TR, Cohen AH, Ehrlich RM, Fine RN (1991) A case report of Drash syndrome in a 46,XX female. Am J Kidney Dis 18:503–508CrossRef

McTaggart SJ, Algar E, Chow CW, Powell HR, Jones CL (2001) Clinical spectrum of Denys-Drash and Frasier syndrome. Pediatr Nephrol 16:335–339CrossRef

Call KM, Glaser T, Ito CY, Buckler AJ, Pelletier J, Haber DA, Rose EA, Kral A, Yeger H, Lewis WH, Jones C, Housman DE (1990) Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms’ tumor locus. Cell 60:509–520CrossRef

10.

Gessler M, Poustka A, Cavenee W, Neve RL, Orkin SH, Bruns GA (1990) Homozygous deletion in Wilms tumours of a zinc-finger gene identified by chromosome jumping. Nature 343:774–778CrossRef

11.

Muñoz-Chápuli R, Carmona R, González-Iriarte M, Macías D, Pérez-Pomares J (2003) Las múltiples caras del gen WT1: funciones en el desarrollo e implicaciones clínicas. Acta Pediatr Méx 24:29–38

12.

Morrison AA, Viney RL, Saleem MA, Ladomery MR (2008) New insights into the function of the Wilms tumor suppressor gene WT1 in podocytes. Am J Physiol Renal Physiol 295:F12–F17CrossRef

13.

Jeanpierre C, Denamur E, Henry I, Cabanis MO, Luce S, Cecille A, Elion J, Peuchmaur M, Loirat C, Niaudet P, Gubler MC, Junien C (1998) Identification of constitutional WT1 mutations, in patients with isolated diffuse mesangial sclerosis, and analysis of genotype/phenotype correlations by use of a computerized mutation database. Am J Hum Genet 62:824–833CrossRef

14.

Schumacher V, Scharer K, Wuhl E, Altrogge H, Bonzel KE, Guschmann M, Neuhaus TJ, Pollastro RM, Kuwertz-Broking E, Bulla M, Tondera AM, Mundel P, Helmchen U, Waldherr R, Weirich A, Royer-Pokora B (1998) Spectrum of early onset nephrotic syndrome associated with WT1 missense mutations. Kidney Int 53:1594–1600CrossRef

15.

Fukuzawa R, Sakamoto J, Heathcott R, Hata J (2002) A necropsy case of Denys-Drash syndrome with a mutation in exon 7 WT1. J Med Genet 39:48–50CrossRef

16.

National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents (2004) The Fourth Report on the Diagnosis, Evaluation, and Treatment of High Blood Pressure in Children and Adolescents. Pediatrics 114:555–576CrossRef

17.

Niaudet P, Gubler MC (2006) WT1 and glomerular diseases. Pediatr Nephrol 21:1653–1660CrossRef

18.

Yamamoto K, Santo Y, Satomura K (2003) A case of Denys-Drash syndrome with prophylactic bilateral nephrectomy. Nippon Jinzo Gakkai Shi 45:42–46PubMed

19.

Rodríguez F (2000) Disgenesias gonadales. In: Tratado de endocrinología pediátrica y de la adolescencia. Madrid, pp 797–818

20.

Jadresic L, Leake J, Gordon I, Dillon MJ, Grant DB, Pritchard J, Risdon RA, Barratt TM (1990) Clinicopathologic review of twelve children with nephropathy, Wilms tumor, and genital abnormalities (Drash syndrome). J Pediatr 117:717–725CrossRef

21.

Kist-van Holthe JE, Ho PL, Stablein D, Harmon WE, Baum MA (2005) Outcome of renal transplantation for Wilms’ tumor and Denys-Drash syndrome: a report of the North American Pediatric Renal Transplant Cooperative Study. Pediatr Transplant 9:305–310CrossRef

22.

Stallmach T, Neuhaus TJ, Kosters R, Hailemariam S (1998) Glomerulopathy in Denys-Drash syndrome. Case report of a model disease. Pathologe 19:230–234CrossRef

23.

Auber F, Lortat-Jacob S, Sarnacki S, Jaubert F, Salomon R, Thibaud E, Jeanpierre C, Nihoul-Fekete C (2003) Surgical management and genotype/phenotype correlations in WT1 gene-related diseases (Drash, Frasier syndromes). J Pediatr Surg 38:124–129CrossRef

24.

Hahn H, Cho YM, Park YS, You HW, Cheong HI (2006) Two cases of isolated diffuse mesangial sclerosis with WT1 mutations. J Korean Med Sci 21:160–164CrossRef

25.

Hinkes B, Wiggins RC, Gbadegesin R, Vlangos CN, Seelow D, Nurnberg G, Garg P, Verma R, Chaib H, Hoskins BE, Ashraf S, Becker C, Hennies HC, Goyal M, Wharram BL, Schachter AD, Mudumana S, Drummond I, Kerjaschki D, Waldherr R, Dietrich A, Ozaltin F, Bakkaloglu A, Cleper R, Basel-Vanagaite L, Pohl M, Griebel M, Tsygin AN, Soylu A, Muller D, Sorli CS, Bunney TD, Katan M, Liu J, Attanasio M, O’Toole JF, Hasselbacher K, Mucha B, Otto EA, Airik R, Kispert A, Kelley GG, Smrcka AV, Gudermann T, Holzman LB, Nurnberg P, Hildebrandt F (2006) Positional cloning uncovers mutations in PLCE1 responsible for a nephrotic syndrome variant that may be reversible. Nat Genet 38:1397–1405CrossRef

26.

Gbadegesin R, Hinkes BG, Hoskins BE, Vlangos CN, Heeringa SF, Liu J, Loirat C, Ozaltin F, Hashmi S, Ulmer F, Cleper R, Ettenger R, Antignac C, Wiggins RC, Zenker M, Hildebrandt F (2008) Mutations in PLCE1 are a major cause of isolated diffuse mesangial sclerosis (IDMS). Nephrol Dial Transplant 23:1291–1297CrossRef

27.

Barbaux S, Niaudet P, Gubler MC, Grunfeld JP, Jaubert F, Kuttenn F, Fekete CN, Souleyreau-Therville N, Thibaud E, Fellous M, McElreavey K (1997) Donor splice-site mutations in WT1 are responsible for Frasier syndrome. Nat Genet 17:467–470CrossRef

28.

Gwin K, Cajaiba MM, Caminoa-Lizarralde A, Picazo ML, Nistal M, Reyes-Mugica M (2008) Expanding the clinical spectrum of Frasier syndrome. Pediatr Dev Pathol 11:122–127CrossRef

29.

Denamur E, Bocquet N, Baudouin V, Da Silva F, Veitia R, Peuchmaur M, Elion J, Gubler MC, Fellous M, Niaudet P, Loirat C (2000) WT1 splice-site mutations are rarely associated with primary steroid-resistant focal and segmental glomerulosclerosis. Kidney Int 57:1868–1872CrossRef

30.

Jensen JC, Ehrlich RM, Hanna MK, Fine RN, Grunberger I (1989) A report of 4 patients with the Drash syndrome and a review of the literature. J Urol 141:1174–1176CrossRef

31.

Habib R, Gubler MC, Antignac C, Loirat C, Gangnadoux MF (1990) Congenital or childhood nephrotic syndrome with diffuse mesangial sclerosis. Ann Pediatr (Paris) 37:73–77

32.

Coppes MJ, Liefers GJ, Higuchi M, Zinn AB, Balfe JW, Williams BR (1992) Inherited WT1 mutation in Denys-Drash syndrome. Cancer Res 52:6125–6128PubMed

33.

Mueller RF (1994) The Denys-Drash syndrome. J Med Genet 31:471–477CrossRef

34.

Ozen S, Tinaztepe K (1996) Diffuse mesangial sclerosis: a unique type of congenital and infantile nephrotic syndrome. Nephron 72:288–291CrossRef

Title: Evolutive study of children with diffuse mesangial sclerosis
Authors: Ana Pilar Nso Roca
Antonia Peña Carrión
Marta Benito Gutiérrez
Carmen García Meseguer
Araceli García Pose
Mercedes Navarro
Publication date: 01-05-2009
Publisher: Springer Berlin Heidelberg
Published in: Pediatric Nephrology / Issue 5/2009
Print ISSN: 0931-041X
Electronic ISSN: 1432-198X
DOI: https://doi.org/10.1007/s00467-008-1063-z

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Evolutive study of children with diffuse mesangial sclerosis

Abstract

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 5/2009

Non-urate transporter 1-related renal hypouricemia and acute renal failure in an Israeli–Arab family

Update on pediatric pheochromocytoma

Streptococcal zymogen type B induces angiotensin II in mesangial cells and leukocytes

Outcome of severe acute post-streptococcal glomerulonephritis in New Zealand children

Hypertension after renal transplantation

Growth hormone treatment started in the first year of life in infants with chronic renal failure